Analysis of MTR and MTRR Polymorphisms for Neural Tube Defects Risk Association

Medicine (United States)

Volumn 94, Issue 35, 2015, Pages e1367-

  Wang, Yongxin ^a   Liu, Yuan ^a   Ji, Wenyu ^a   Qin, Hu ^a   Wu, Hao ^a   Xu, Danshu ^a   Tukebai, Turtuohut ^a   Wang, Zengliang ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; FOLIC ACID; HAPTOCORRIN; HOMOCYSTEINE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; TRANSCOBALAMIN; 5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE;

ALLELE; ANENCEPHALUS; ARTICLE; BLOOD SAMPLING; CHILD; CHINESE; CONTROLLED STUDY; FEMALE; FIRST DEGREE RELATIVE; FOLIC ACID BLOOD LEVEL; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NEURAL TUBE DEFECT; OCCULT SPINAL DYSRAPHISM; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; FERREDOXIN-NADP REDUCTASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEURAL TUBE DEFECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84944875651     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001367     Document Type: Article

References (35)

1. Ouyang S, Liu Z, Li Y, et al. Cystathionine beta-synthase 844ins68 polymorphism is unrelated to susceptibility to neural tube defects. Gene. 2014;535:119-123.
2. Marini NJ, Hoffmann TJ, Lammer EJ, et al. A genetic signature of spina bifida risk from pathway-informed comprehensive gene-variant analysis. PLoS One. 2011;6:e28408.
3. Li Z, Ren A, Zhang L, et al. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol. 2006;76:237-240.
4. Detrait ER, George TM, Etchevers HC, et al. Human neural tube defects: developmental biology, epidemiology, and genetics. Neuro-toxicol Teratol. 2005;27:515-524.
5. Zhang T, Lou J, Zhong R, et al. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLoS One. 2013;8:e59570.
6. Blom HJ, Shaw GM, den Heijer M, et al. Neural tube defects and folate: case far from closed. Nat Rev Neurosci. 2006;7:724-731.
7. De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, et al. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010:CD007950.
8. Kibar Z, Capra V, Gros P. Toward understanding the genetic basis of neural tube defects. Clin Genet. 2007;71:295-310.
9. O'Leary VB, Mills JL, Pangilinan F, et al. Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab. 2005;85:220-227.
10. Etheredge AJ, Finnell RH, Carmichael SL, et al. Maternal and infant gene-folate interactions and the risk of neural tube defects. Am J Med Genet A. 2012;158A:2439-2446.
11. Lucock M, Daskalakis I, Briggs D, et al. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c ! t methylenetetrahydrofolate reductase and 2756a ! g methionine synthase genotypes. Mol Genet Metab. 2000;70:27-44.
12. Yadav U, Kumar P, Yadav SK, et al. Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis. Metab Brain Dis. 2014;30:7-24.
13. Olteanu H, Wolthers KR, Munro AW, et al. Kinetic and thermo-dynamic characterization of the common polymorphic variants of human methionine synthase reductase. Biochemistry. 2004;43:1988-1997.
14. Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry. 2002;41:13378-13385.
15. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
16. Candito M, Rivet R, Herbeth B, et al. Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: a multicenter case-control study. Am J Med Genet A. 2008;146A:1128-1133.
17. Naushad SM, Devi AR. Role of parental folate pathway single nucleotide polymorphisms in altering the susceptibility to neural tube defects in South India. J Perinat Med. 2010;38:63-69.
18. Relton CL, Wilding CS, Laffling AJ, et al. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab. 2004;81:273-281.
19. Ratan SK, Rattan KN, Pandey RM, et al. Evaluation of the levels of folate, vitamin B12, homocysteine and fluoride in the parents and the affected neonates with neural tube defect and their matched controls. Pediatr Surg Int. 2008;24:803-808.
20. Wenstrom KD, Johanning GL, Owen J, et al. Amniotic fluid homocysteine levels, 5, 10-methylenetetrahydrafolate reductase genotypes, and neural tube closure sites. Am J Med Genet. 2000;90:6-11.
21. Lacasana M, Blanco-Munoz J, Borja-Aburto VH, et al. Effect on risk of anencephaly of gene-nutrient interactions between methylene-tetrahydrofolate reductase C677T polymorphism and maternal folate, vitamin B12 and homocysteine profile. Public Health Nutr. 2012;15:1419-1428.
22. Bailey RL, Dodd KW, Gahche JJ, et al. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003-2006. Am J Clin Nutr. 2010;91:231-237.
23. Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000;71:1295S-1303S.
24. Dunlevy LP, Chitty LS, Burren KA, et al. Abnormal folate metabolism in foetuses affected by neural tube defects. Brain. 2007;130:1043-1049.
25. Harmon DL, Shields DC, Woodside JV, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol. 1999;17:298-309.
26. Leclerc D, Wilson A, Dumas R, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA. 1998;95:3059-3064.
27. Anwar W, Gueant JL, Abdelmouttaleb I, et al. Hyperhomocysteine-mia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis. Clin Chem Lab Med. 2001;39:747-752.
28. Silaste ML, Rantala M, Sampi M, et al. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr. 2001;131:2643-2647.
29. Chen J, Stampfer MJ, Ma J, et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis. 2001;154:667-672.
30. Dekou V, Gudnason V, Hawe E, et al. Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men. Thromb Haemost. 2001;85:67-74.
31. Ma J, Stampfer MJ, Christensen B, et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8:825-829.
32. Gos M, Sliwerska E, Szpecht-Potocka A. Mutation incidence in folate metabolism genes and regulatory genes in Polish families with neural tube defects. J Appl Genet. 2004;45:363-368.
33. Geisel J, Zimbelmann I, Schorr H, et al. Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med. 2001;39:698-704.
34. Bassuk AG, Kibar Z. Genetic basis of neural tube defects. Semin Pediatr Neurol. 2009;16:101-110.
35. Ulrich CM, Robien K, McLeod HL. Cancer pharmacogenetics: polymorphisms, pathways and beyond. Nat Rev Cancer. 2003;3:912-920.